Short answer
By revenue in their latest annual reports, the largest US healthcare companies are UnitedHealth Group ($447.6 billion in 2025), McKesson ($403.4 billion in the year to March 2026), CVS Health ($402.1 billion), Cencora ($321.3 billion in the year to September 2025) and The Cigna Group ($274.9 billion). Insurers, pharmacy benefit managers and drug distributors fill the top nine places; the biggest drugmaker, Johnson & Johnson, is 11th. Figures come from each company's 10-K or, for Kaiser Permanente, its results release.
- UnitedHealth Group reported $447.6 billion of revenue and more than 390,000 employees in 2025, nearly 165,000 of them clinical professionals.
- The three big drug distributors, McKesson, Cencora and Cardinal Health, reported $979 billion of revenue between them but employ about 158,000 people.
- HCA Healthcare is the largest hospital company in the table, with $75.6 billion of revenue and about 320,000 employees.
- Walgreens left the public markets in August 2025, when funds managed by Sycamore Partners completed their acquisition, so it no longer files results.
- The Census Bureau counted 1,003,398 health care and social assistance establishments in 2023, employing 22.1 million people.
On this page
This list is for people who sell into healthcare: software and data vendors, staffing and services firms, suppliers of equipment and consumables, logistics providers, consultants and agencies. It ranks the 25 largest US healthcare companies by revenue from their latest annual reports, groups them by where they sit in the flow of money, and explains where buying decisions are made at each type.
The 25 largest healthcare companies in the US
Revenue as reported for each company's latest fiscal year filed by 30 October 2026. All file 10-Ks with the SEC except Kaiser Permanente, a nonprofit that publishes its results.
| Rank | Company | Headquarters | What it does | Revenue | Fiscal year | Employees |
|---|---|---|---|---|---|---|
| 1 | UnitedHealth Group | Eden Prairie, MN | Health insurance and Optum health services | $447.6 billion | 2025 | more than 390,000 |
| 2 | McKesson | Irving, TX | Drug and medical supply distribution | $403.4 billion | year to March 2026 | more than 43,000 |
| 3 | CVS Health | Woonsocket, RI | Pharmacies, pharmacy benefits and Aetna insurance | $402.1 billion | 2025 | more than 300,000 |
| 4 | Cencora | Conshohocken, PA | Drug distribution | $321.3 billion | year to September 2025 | more than 51,000 |
| 5 | The Cigna Group | Bloomfield, CT | Pharmacy benefits (Evernorth) and insurance | $274.9 billion | 2025 | about 67,700 |
| 6 | Cardinal Health | Dublin, OH | Drug and medical product distribution | $254.2 billion | year to June 2026 | about 63,900 |
| 7 | Elevance Health | Indianapolis, IN | Health insurance | $199.1 billion | 2025 | about 97,100 |
| 8 | Centene | St. Louis, MO | Health insurance (Medicaid, Marketplace, Medicare) | $194.8 billion | 2025 | about 61,100 |
| 9 | Humana | Louisville, KY | Health insurance (mainly Medicare) | $129.7 billion | 2025 | about 67,060 |
| 10 | Kaiser Permanente with Risant Health | Oakland, CA | Nonprofit health plan and hospitals | $127.7 billion | 2025 | not in its results release |
| 11 | Johnson & Johnson | New Brunswick, NJ | Medicines and medical technology | $94.2 billion | 2025 | about 140,800 |
| 12 | HCA Healthcare | Nashville, TN | Hospitals and outpatient care | $75.6 billion | 2025 | about 320,000 |
| 13 | Eli Lilly | Indianapolis, IN | Medicines | $65.2 billion | 2025 | about 50,000 |
| 14 | Merck & Co. | Rahway, NJ | Medicines and animal health | $65.0 billion | 2025 | about 75,000 |
| 15 | Pfizer | New York, NY | Medicines and vaccines | $62.6 billion | 2025 | about 75,000 |
| 16 | AbbVie | North Chicago, IL | Medicines | $61.2 billion | 2025 | about 57,000 |
| 17 | Bristol Myers Squibb | Princeton, NJ | Medicines | $48.2 billion | 2025 | about 32,500 |
| 18 | Molina Healthcare | Long Beach, CA | Health insurance (Medicaid, Medicare, Marketplace) | $45.4 billion | 2025 | about 19,000 |
| 19 | Thermo Fisher Scientific | Waltham, MA | Lab equipment, life science tools and services | $44.6 billion | 2025 | about 125,000 |
| 20 | Abbott | Abbott Park, IL | Devices, diagnostics, nutrition and medicines | $44.3 billion | 2025 | about 115,000 |
| 21 | Amgen | Thousand Oaks, CA | Biotechnology medicines | $36.8 billion | 2025 | about 31,500 |
| 22 | Medtronic | Galway, Ireland | Medical devices | $36.4 billion | year to April 2026 | more than 95,000 full-time |
| 23 | Gilead Sciences | Foster City, CA | Biotechnology medicines | $29.4 billion | 2025 | about 17,000 |
| 24 | Stryker | Portage, MI | Medical devices | $25.1 billion | 2025 | about 56,000 |
| 25 | Danaher | Washington, DC | Life sciences and diagnostics | $24.6 billion | 2025 | about 60,000 |
Revenue is total revenue as reported. Medtronic is legally domiciled in Ireland and files a 10-K; its principal executive office is in Galway. Employee counts are as of each fiscal year end. Just below the cut: Becton Dickinson ($21.8 billion, year to September 2025) and Tenet Healthcare ($21.3 billion).
Where the money flows
Grouping the 25 companies by what they mainly do (our classification; CVS and Cigna straddle two groups):
| Group | Companies in the table | Combined revenue | How revenue is earned |
|---|---|---|---|
| Health insurers and integrated plans | UnitedHealth, Elevance, Centene, Humana, Kaiser, Molina | $1,144 billion | Premiums from employers, individuals and government programs, plus services |
| Drug distributors | McKesson, Cencora, Cardinal Health | $979 billion | The price of medicines they buy from manufacturers and resell to pharmacies and hospitals |
| Pharmacy and pharmacy benefits | CVS Health, Cigna | $677 billion | Prescriptions dispensed and managed, plus insurance |
| Drugmakers | J&J, Lilly, Merck, Pfizer, AbbVie, BMS, Amgen, Gilead | $463 billion | Sales of medicines (and J&J's medical technology) |
| Devices, diagnostics and tools | Thermo Fisher, Abbott, Medtronic, Stryker, Danaher | $175 billion | Equipment, implants, tests and lab supplies |
| Hospitals | HCA Healthcare | $76 billion | Payments for patient care from insurers, Medicare, Medicaid and patients |
The distributors show why revenue overstates size in healthcare. McKesson, Cencora and Cardinal Health together reported $979 billion of revenue but about 158,000 employees, because most of what they bill is the cost of medicines passing through. HCA, with a fifth of McKesson's revenue, employs about 320,000 people, including about 90,000 part-time and PRN staff.
How this list is built
- What's counted. Total revenue in the consolidated income statement for each company's latest fiscal year, as filed by 30 October 2026. Fiscal years differ: McKesson's ended in March 2026, Cardinal Health's in June 2026 and Cencora's in September 2025, so the table compares different 12-month periods.
- Who's in scope. US-listed companies whose main business is healthcare, plus Kaiser Permanente, which publishes its results. Medtronic is included because it files 10-Ks and reports in dollars.
- Who's left out. Walgreens, which was acquired by affiliates of funds managed by Sycamore Partners on 28 August 2025 and stopped filing; nonprofit hospital systems other than Kaiser (see the largest hospital systems); and healthcare companies based outside the US, such as Roche (about $74.1 billion in 2025; see the largest pharmaceutical companies).
- Other lists. Fortune's healthcare sectors and market-value rankings from financial sites use other measures and dates. We didn't copy them.
How many healthcare businesses there are in the US
County Business Patterns counts establishments with paid employees. For 2023:
| Industry (NAICS) | Establishments | Employees | Annual payroll |
|---|---|---|---|
| Health care and social assistance (62) | 1,003,398 | 22,063,238 | $1.39 trillion |
| Ambulatory health care, including physician offices (621) | 701,862 | 8,697,480 | $621.1 billion |
| Hospitals (622) | 7,523 | 6,344,178 | $511.8 billion |
| Nursing and residential care facilities (623) | 94,771 | 3,278,910 | $136.6 billion |
| Drug wholesalers (424210) | 8,919 | 302,952 | $48.4 billion |
| Surgical and medical instrument manufacturing (339112) | 1,310 | 132,354 | $12.4 billion |
Hospitals are few but huge: 1,772 of the 7,523 hospital establishments have 1,000 or more employees. Ambulatory care is the reverse: 367,109 of its 701,862 establishments have fewer than five.
Where buying decisions sit
General guidance, by type of company:
- Insurers. Claims, clinical and care management, distribution and IT leaders each own budgets; see the largest health insurance companies for how those markets split.
- Distributors. Distribution center operations, transportation, IT and supplier relations. Decisions about warehouse equipment, automation and transport are made regionally within national standards.
- Pharmacy and benefits. Pharmacy operations, store and clinic leaders, and the benefits business, which sells to employers and health plans.
- Drugmakers and device makers. Research and clinical operations, manufacturing sites, quality and commercial teams, with procurement running supplier qualification.
- Hospitals. Supply chain, nursing, IT, facilities and finance, often decided at system level for large contracts and at the hospital for smaller ones. The guide to selling to hospitals covers the committee process.
Worked example: a contract manufacturer selling to medical device makers
Illustrative example. The company, its prices and its conversion rates are invented; establishment counts come from County Business Patterns 2023.
The seller: Keystone Precision (keystone-precision.example), which machines and finishes implant and instrument components under an ISO 13485 quality system. The goal: two new device customers in a year.
- Size the market. There are 1,310 surgical and medical instrument manufacturing establishments in the US. 284 of them have 100 or more employees, the size that usually buys outsourced components.
- Name the targets. Start with the device makers in the table (Medtronic, Stryker, Abbott, J&J's MedTech business) and their 10-K property sections, then add mid-size and private manufacturers.
- Find the people. Supplier development or sourcing managers, the manufacturing engineering lead for the product line, and quality.
- Do the arithmetic. If Keystone reaches the right people at half of the 284 sites (142), and 10% start a supplier qualification (14), winning 3 at an assumed $400,000 a year each would add $1.2 million of annual revenue, after a qualification that can take most of a year.
Matching each site to its sourcing and engineering contacts is the slow part at this volume; Bebop researches each account in a list and writes a playbook for it.
Subject: Second source for [component type] at [company] Hi [first name], I saw [company] is [launching / scaling / moving production of] [product line] at [site]. Sourcing teams at device makers often tell us their risk is a single qualified supplier for machined components on a growing line. We machine and finish [component type] under an ISO 13485 quality system, with documentation ready for supplier qualification. Would 20 minutes be useful to see whether we'd be a fit as a second source? [Your name] [Phone number]
Common mistakes
- Treating revenue as headcount. Distributors bill hundreds of billions with relatively few employees; hospitals the reverse.
- Mixing fiscal years. Note the year end next to every figure.
- Pitching the parent. UnitedHealth, CVS and Cigna each run several businesses with separate budgets.
- Missing the regulators. Medicare, Medicaid, FDA and state rules shape what each type can buy and how fast.
Next step: for one segment in more depth, see the largest health insurance companies.
Sources
- UnitedHealth Group Form 10-K for the fiscal year ended December 31, 2025, UnitedHealth Group Incorporated, via SEC EDGAR, filed 2 March 2026
- McKesson Form 10-K for the fiscal year ended March 31, 2026, McKesson Corporation, via SEC EDGAR, filed 8 May 2026
- CVS Health Form 10-K for the fiscal year ended December 31, 2025, CVS Health Corporation, via SEC EDGAR, filed 10 February 2026
- Cencora Form 10-K for the fiscal year ended September 30, 2025, Cencora, Inc., via SEC EDGAR, filed 25 November 2025
- The Cigna Group Form 10-K for the fiscal year ended December 31, 2025, The Cigna Group, via SEC EDGAR, filed 26 February 2026
- Cardinal Health Form 10-K for the fiscal year ended June 30, 2026, Cardinal Health, Inc., via SEC EDGAR, filed 11 August 2026
- Elevance Health Form 10-K for the fiscal year ended December 31, 2025, Elevance Health, Inc., via SEC EDGAR, filed 6 February 2026
- Centene Form 10-K for the fiscal year ended December 31, 2025, Centene Corporation, via SEC EDGAR, filed 17 February 2026
- Humana Form 10-K for the fiscal year ended December 31, 2025, Humana Inc., via SEC EDGAR, filed 19 February 2026
- Kaiser Permanente and Risant Health report 2025 financial results, Kaiser Permanente, 6 February 2026
- Johnson & Johnson Form 10-K for the fiscal year ended December 28, 2025, Johnson & Johnson, via SEC EDGAR, filed 11 February 2026
- HCA Healthcare Form 10-K for the fiscal year ended December 31, 2025, HCA Healthcare, Inc., via SEC EDGAR, filed 10 February 2026
- Eli Lilly Form 10-K for the fiscal year ended December 31, 2025, Eli Lilly and Company, via SEC EDGAR, filed 12 February 2026
- Merck & Co. Form 10-K for the fiscal year ended December 31, 2025, Merck & Co., Inc., via SEC EDGAR, filed 24 February 2026
- Pfizer Form 10-K for the fiscal year ended December 31, 2025, Pfizer Inc., via SEC EDGAR, filed 26 February 2026
- AbbVie Form 10-K for the fiscal year ended December 31, 2025, AbbVie Inc., via SEC EDGAR, filed 20 February 2026
- Bristol Myers Squibb Form 10-K for the fiscal year ended December 31, 2025, Bristol-Myers Squibb Company, via SEC EDGAR, filed 11 February 2026
- Molina Healthcare Form 10-K for the fiscal year ended December 31, 2025, Molina Healthcare, Inc., via SEC EDGAR, filed 10 February 2026
- Thermo Fisher Scientific Form 10-K for the fiscal year ended December 31, 2025, Thermo Fisher Scientific Inc., via SEC EDGAR, filed 26 February 2026
- Abbott Laboratories Form 10-K for the fiscal year ended December 31, 2025, Abbott Laboratories, via SEC EDGAR, filed 20 February 2026
- Amgen Form 10-K for the fiscal year ended December 31, 2025, Amgen Inc., via SEC EDGAR, filed 13 February 2026
- Medtronic plc Form 10-K for the fiscal year ended April 24, 2026, Medtronic plc, via SEC EDGAR, filed 18 June 2026
- Gilead Sciences Form 10-K for the fiscal year ended December 31, 2025, Gilead Sciences, Inc., via SEC EDGAR, filed 24 February 2026
- Stryker Form 10-K for the fiscal year ended December 31, 2025, Stryker Corporation, via SEC EDGAR, filed 11 February 2026
- Danaher Form 10-K for the fiscal year ended December 31, 2025, Danaher Corporation, via SEC EDGAR, filed 24 February 2026
- Becton, Dickinson and Company Form 10-K for the fiscal year ended September 30, 2025, Becton, Dickinson and Company, via SEC EDGAR, filed 25 November 2025
- Tenet Healthcare Form 10-K for the fiscal year ended December 31, 2025, Tenet Healthcare Corporation, via SEC EDGAR, filed 17 February 2026
- Walgreens Boots Alliance Form 8-K reporting completion of the merger, Walgreens Boots Alliance, Inc., via SEC EDGAR, filed 28 August 2025
- 2023 County Business Patterns datasets (NAICS 62, 621, 622, 623, 424210 and 339112), US Census Bureau, 2025; accessed 30 October 2026
Written by the Bebop team at Blackpearl Group. Published .
Questions people ask
What is the largest healthcare company in the US?
UnitedHealth Group, with $447.6 billion of revenue in 2025 and more than 390,000 employees, according to its 10-K. It combines UnitedHealthcare, the largest US health insurer, with Optum's care delivery, pharmacy benefits and data businesses. McKesson, a drug distributor, is second by revenue with $403.4 billion in the year to March 2026, just ahead of CVS Health ($402.1 billion).
What are the top 10 healthcare companies by revenue?
From their latest annual reports: UnitedHealth Group ($447.6 billion), McKesson ($403.4 billion), CVS Health ($402.1 billion), Cencora ($321.3 billion), The Cigna Group ($274.9 billion), Cardinal Health ($254.2 billion), Elevance Health ($199.1 billion), Centene ($194.8 billion), Humana ($129.7 billion) and Kaiser Permanente with Risant Health ($127.7 billion). Fiscal years differ for McKesson, Cencora and Cardinal Health.
Why are drug distributors among the largest healthcare companies?
Their revenue includes the full price of the medicines they buy from manufacturers and resell to pharmacies, hospitals and clinics, so it's very large compared with the work they do. McKesson, Cencora and Cardinal Health reported $979 billion of revenue between them in their latest fiscal years but employ about 158,000 people, while HCA Healthcare, a hospital operator, employs about 320,000 on $75.6 billion.
Is Walgreens still one of the largest healthcare companies?
Walgreens Boots Alliance is no longer a public company. On 28 August 2025 it was acquired by affiliates of investment funds managed by Sycamore Partners, according to its final 8-K filing, and it then deregistered its shares. Because it no longer publishes annual results, it isn't in this table, which ranks companies by revenue in their latest annual reports.
How many healthcare companies are there in the US?
The Census Bureau's County Business Patterns counted 1,003,398 health care and social assistance establishments in 2023, employing 22,063,238 people. That includes 701,862 ambulatory care establishments such as physician and dental offices, 7,523 hospitals and 94,771 nursing and residential care facilities. These are locations with paid employees, not companies, so one hospital system or clinic chain can account for hundreds of them.